Publication | Open Access

Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer: a phase II study from Indiana University

Indiana UniversityRecombinant Human AngiostatinMedicinePharmacologyPhase Ii StudyBronchial NeoplasmAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer ResearchLung CancerMolecular Oncology